Related Experiment Video
Updated: Oct 10, 2026

Live Imaging of Mitosis in the Developing Mouse Embryonic Cortex
Published on: June 4, 2014
Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases
J W Husseman1, D Nochlin, I Vincent
1Department of Pathology, University of Washington, Box 357705, 1959 NE Pacific Ave, Seattle, WA 98195, USA.
Abstract:
Previous evidence from our lab and others has implicated the mitotic cdc2/cyclin B1 kinase in the neurofibrillary degeneration of Alzheimer's disease. To examine the specificity of this relationship, and define conditions leading to atypical activation of mitotic kinase in postmitotic neurons, we have applied antibodies specific for the cdc2 kinase, its activator, cyclin B1, and three cdc2 produced phosphoepitopes: the TG-3 phosphoepitope in tau and nucleolin, the MPM-2 phosphoepitope in a variety of substrates, and the H5 phosphoepitope in RNA polymerase II, to affected brain regions from a spectrum of neurodegenerative disorders. Our results demonstrate that neurons containing characteristic lesions in a subset of diseases including Down Syndrome (DS), Frontotemporal Dementia linked to chromosome 17 (FTD-17), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Parkinson-Amyotrophic Lateral Sclerosis of Guam (GP-ALS), Niemann Pick disease type C (NPDC), and Pick's disease, display mitotic indices, implicating diverse etiologies in mitotic activation. The convergence of various degenerative schemes into a unified mitotic kinase-driven pathway provides a common target for therapeutic treatment of these different disorders.
Insights
Mitotic kinase activation is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's. This suggests a common therapeutic target for diverse brain disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- The mitotic cdc2/cyclin B1 kinase is linked to neurofibrillary degeneration in Alzheimer's disease.
- Understanding atypical mitotic kinase activation in neurons is crucial for neurodegenerative disease research.
Purpose of the Study:
- To investigate the specificity of the cdc2/cyclin B1 kinase in neurodegeneration.
- To define conditions causing atypical mitotic kinase activation in postmitotic neurons across various disorders.
Main Methods:
- Antibodies targeting cdc2 kinase, cyclin B1, and specific phosphoepitopes (TG-3, MPM-2, H5) were used.
- Affected brain regions from patients with diverse neurodegenerative disorders were analyzed.
Main Results:
- Neurons with characteristic lesions in Down Syndrome, FTD-17, PSP, CBD, GP-ALS, NPDC, and Pick's disease showed mitotic indices.
- These findings implicate diverse etiologies in activating mitotic pathways.
Conclusions:
- A unified mitotic kinase-driven pathway converges various neurodegenerative processes.
- This pathway presents a common therapeutic target for multiple neurodegenerative disorders.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Meiosis I
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Anaphase Promoting Complex
